Filter by
Filter by
Biochemical Results, Toxicity, Patient QoL After Delivery of Dose-Escalated Image Guided PT for Prostate Cancer
A large series of 1327 localized prostate cancer patients reported 5-year biochemical control rate, toxicity and patient-reported quality of life after proton...
Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer.
This study compared the bowel function (BF), urinary irritative/obstructive symptoms (UO), and urinary incontinence (UI) domains of EPIC-26 collected in 262...
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis. This review.
Published in the Green Journal, this systematic review analyzed 160 studies of hypofractionated PT (n=11) or XRT (n=148) or PT+XRT (n=1) for localized prostate...
A Single-Institution Prospective Study To Evaluate the Safety and Efficacy of Real- Time Image-Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer.
This study from Japan reported 45 cases of localized prostate cancer treated with real-time image-gated spot-scanning proton therapy (RGPT) where 3 to 4 pure...
A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity-Modulated Radiation Therapy in Early Stage Prostate Cancer Patients.
This multi-institutional study compared late toxicity profiles of a total of 1850 patients, including 1282 IMRT and 568 PBT. Overall toxicity rates were low...